CC
AMRX icon

Centiva Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Centiva Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,471
Closed -$465K – 1084
2025
Q2 		$465K Buy
57,471
+14,173
+33% +$107K 0.03% 992
2025
Q1 		$363K Buy
+43,298
New +$361K 0.02% 985
2024
Q3 		– Sell
-57,139
Closed -$363K – 2105
2024
Q2 		$363K Sell
57,139
-547
-0.9% -$3.47K 0.02% 1361
2024
Q1 		$350K Buy
+57,686
New +$325K 0.02% 1168
2023
Q4 		– Sell
-31,912
Closed -$135K – 1765
2023
Q3 		$135K Buy
+31,912
New +$119K 0.01% 1465
2021
Q4 		– Sell
-22,752
Closed -$121K – 1178
2021
Q3 		$121K Buy
+22,752
New +$115K 0.01% 1009

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return